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AClllc otlm l11eJi:t (AOM) IS one of thl' 1II0St cOl11l11on disease,
f 1I11:1I1t ~nd chlldrell; more tlun ')0% of dllldrm 'ounger
than 3 Yl'ars of age de\'dop .1t lea.11 ontO ,~pls()de: o( this disease:
and l110re than .jO'X. utrer from morc than one arrack II].
AOM IS g':-IleraLly a nllid ,liseate, hllt, occasionaLly, It ean lead
to senOllS and pml'IlmIly life thrl'arening complications, s\lch as
ma,tOldins, mcIllngltls, sepsIs and sewn: aUllirory so.:'1uebe [2,31·
AOM IS a llJclt:n~l di,easl' 111 7CJ'Yc.-HO%, of the Clses and,
heCJu>e it it not possibl..- 10 distin~uish clinicaLly chosl' cascs
thaI have: a SpOI1t:lllCOUS good "rognoSI (i'om thos" that l11ay
..-volve ne!--':ltively, mo,c of thl' Ilpimon I"ade'" in l'edi,mi
II1fectious dls"ascI SU~f;C\t syscL"matic prescription of
anriblOtlcs In aU the cases. However, although A M can
pOIlt:lllCOusly rcsoh'e III most ca.les, II Il.lS becn demonstraced
Ih31 me o( a11lihlOtict r..-dun" Ihe ill lelellce u( ompllcatlons,
prt"vel1ts progr..-ssioll to chronic nnm Illedla WIth eHi-lslon and
relieves 'yIl11'[()m, m il ,horter time, thus permitting ~ fum:r
rerum to d:l -care (I:men. or to ,ch 01.
U,'Cl,~nal p3thogcns usually cultured fr m middlc car Iluid
colJecr.:d by tympallOCt'llCe,ls Junl1g an epIsode of A Mar"
Strel'tlllll(e'II' l'IIl'/I/1/(1I1;(/f (5.1'11,), / lrll'lIItll'hilw iI!{lIII'"ZtII' (H .1.),
M",,,,\·!,II,, ((/tanlr"/i" (M.e) ,III I SlrCp''''"(I'IIS /')','.':e/ll's (, .p,).
AlIloxicilJlI1 IS ,lCllve ~~aillSt .11 tllt'se bacn:n, , and IS saf,', Iwll
lOkracnl aIIII rh"Jr. Thaef{)re, it 11:1, been <: llSldered till'
drug of chOICe lor At lM smco.: liS inITodllClioll on thl' llIarkN
[4-(,1. Until the he!--'1nnmg of the )98()s tillS "pullon was never
debated hut d'l' .:meq,(ell<:t' of reSlSc~n<:e of H.1. and M ,c, posl'd
Ihe que,tioll of Iht' possible substitlltlOIl or amoxlcilJin with
difierelll anriblollc, able to resl. I [( ~-"Icwlllases, Amol1g thl'
p<>ssibk altcrn:mves 10 allloxicillin, :1I11oxicillill- Iavlllan:lte
combination, n.:celltly lll:lrk,'led llI:lCrolid,'s ~lId second- ~l1d
tlmd-gellcr~tlon 01'711 cd;,phalo,porlns were ilHhc.lIed [7,HI.
However, use or ,lmoxlcilllll-cla\'lll:l11:1te comblllaUOIl w~s
followed by ~n IIl'reaseJ nsk of f..':lstr\)lntestm~l S1dl,-etli:cts,
alld 1II,ICro!llkl were C Illlliert'.! less sunable be -:lIlS" In sonlt'
geol;V:lphic arcas high !l'rC':-lItages or S.p, weI'" re,ist,11ll to
thelc druh'" Thadart', St'cond-alld third-gelll'r;ltion oral
e;eph;tlosporin, be -:llll... th ... Illost cOlllmollly prescribed alter-
I1JtJves to ,lllloXlcllhl1. St'v,'ral c1illlcaltnals delllonstrated their
CurrC'p"Illhllt:( ~Iltilor ,ll1d rCl'l'Inl ""I"CSt>: N, llia I'nlh:ll'i, blllnto
UlllIll JJ I'crtcZlOIlJIllelllO, JllllC,l l'cdl.llnca, Ulll\'eJ'lIG' ,t. M,11.1I10, l~lly
Fax,: +J'J 02 55l 95J~ I
dl'icacy, safety and tolerahllity 11l AOM. At usu~1 ther.tpeutlc
loses all these compunds were conslder...d to h:l\'e a sillubr
dimcal and microbloJogtc:ll cHicacy and ulom.lIt: ch ICC
depcnds on sarcry, tokr.tblhry and cm! on.mlcratlom [6].
A,· the be~lI1ning of thl' 19c)(), a n...w prohll'l11 of reSIScance
among thl' AOM pathogens Jrose: III severa! councn.:s, a
slgll.lficanr proportion 0 S.pn. became pem illm reSIStant. A5
wilh pl'mcillill, several other antihlOtics were lI1c1uded 1II thiS
tonn o( resist, n e, and the r01o: of ecol1o- and chlrd-
generarioll oral cephalosp rim III th ... cr...anm'nc of AOM was
re onsidcred r9-121, Tak.ing inro account bom phanllJcoki-
lIeck and piumucodynallllc chara I... nsncs of all these
alltiblOti s, It was dt'l1lonsrrated thH most 0 the cephalospor-
ins did n t hav" propCrtlC good enough to ov..-rcollle the
problem of .pn, rC.lsrance. or parncu!. I' lIllerC t I the lenp;t.h
of time becw...en doses during willch conc...ll1ratwns of the
van us oral ceph.lmporins remain high... r 11uII the Irul1llna!
inhibilOry concenu'ation (MIC) for the !nfc ong pathogen.
tarring trom the prcnllse that to havt' a slgJlIficam probability
of eradlcanng the p~thogen present In the nuddJe car flUId n
'lllnblOtlC musr r':-llJain at the sIte )r the II1rccuon at a
concentratioll hIgher than the MIC for at kast a p"nod
corrl'spunuing t 30%-:;{)% of tne dose Inr,'rval, II \t d lea Iy
dt:lllollst.rar..-d (Table I) that onJy ce uroxll1lc-a.xenl and, to a
lesset "XCcnt, cetprozil may have a chance of bell1g eileen"c III
AOM duc to pClllcillin-reS!Stant ,pn., at leasl when less
r...slst'ant >tram.' ~re invoked 11-11.
Or~1 cephalosponm were also IIlvolved 111 a econd problem
concerning the therapy I)f A I. thal \\'hl h on'lders lhe
l'0sslbk pres npnon of the :lnablotic for 3 penod of rune
shortcr thall chat usually used, It IS <:UITelll 0plIlion that ~ 11)-
day ourse i, the best way to obtalll a cur...: howcv...r, II is
dillicu!t to lllallllalll the antibIOtic therapy tor a lon~ as thB,
espeCiall III IIIfi:CtiOllS such as AOM, w(ueh have a very ~ood
dmical rt'pon e III 3 days, A,. comcljuellce, cOlllphancc
may be reduced .1Ild the n. k ort~lilu~ can b,' lllghl)' lIlcrcasl'd.
, () ~cver:t1 trials e ,llIat<'d ,hOltened treaUllel1l reglmem lor
AOM WIth che ust' of oral ccphalmponns (Tahle 2). The'
collected data cal1not be conSIdered concluSl\'c b"cam,' the
Illiluber of ellrolleu patients IS small. HOI ever, an OV... r:lU
..-valuratioll )( t1w data sllgges~ that shortened cou"e of
thaapy :lnllOt be 'ystenlallCJlly used 111 AOM. WIth a
,h rll'ned cOllr.,' Ill' thl·r.lpy, \ hatevcr the dnag used, an
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Table 1 ShorHorm therapy wuh o,al ccphalosportns for acute OIlIlS mad'a
Therapy
Calnc/or 5 days vs Amoxic,I"na 10 <lays
Celador 5 days yj; Celaclo, 10 days
Calurox,me 5 d vs Amoxl + AC Clav.1 0 d
Cefpodoximo 5 d vs, Cefixlme 8 d
Cefpodoxime 5 d vs AOloxl AC Clav 8 d
Modified. from (13J
Age (no. of cases)
501-6 y (27)
, m-l0 y (59)
301-12 y (242)




5 davs less effective ,I perlorot'on of oord,um
No difference < ADA wl\h 5 days
No difference
No dilference












































IIlcreas~ n k El.Ilurc seems po >fblc In tho e e:t'IC wher' the
tyl1lp3IUC membrane is perforated and in younger infants and
children. In omr:m. no problent~ arc preSent when older
c1uJdren ~nd uncomplicated cn e.s arc evaluated [1 (t-27]. II is
lear thaI a shortened c une of anabiotic administration is .
goal ofantibIOtiC therapy be aust it Increases compliance. thus
reducll1g d1l' osk of failure. it limits the dcvclopmelll of
undesIrable Id.:-dfectS nd il reduces rhe economic co t of the
trearment. H wever. ir can be sugg ted only when there u a
clear definirion of which p. ticnrs 111. y really b ncfir frOI11 .
simplified eheme of thcrapy . nd which children may have. n
II1creascd nsk of f.Jilure. Because thO is not clearly estabUshed
for A M. it i§ reasonable to suggest th:lt in orrectly diagnosed
A M ora.! cephalosponl15 arc gIVen for J0 day .. c 'urately
mUllItonng drug admini!ltration, afety nd rulcrability.
In con IUSIOIl. 50me ora.! cepnalo~orins. ueh. s efilroXlme
eoJ and cdpr ziJ, re.rnam tne drugs of choicc to tTc tAM
f inf.ln and chll ren aU over the world, even in those
countries where dlere are problems of resi tance t amox-
icillin, OWing to production of p-laromasCi by H.i. and M.c.
and for modificaaon of PBP by S.pn. ther oral ceplulospor-
1m may be valid .Itematives to amoxi ilIlII where the only
problem it H,I. and M.e. r istanec. In all A Ms, rhey must be
admini tercd for I day unol the problem f which hUdren
migbt receive a shoreer tre:ttment is d . rly solved. Am nl; the
various compounds of tltis antibiotic group the choice of the
best drug ro use In those cases in which clirucal and
mlcrobiol gical effi cy n he c nsidered quile imilar h. s
to be upponcd by a precise conSideration ofsafety, tolerability
and economic ost. A •reful eVllluatlon of clinical rrial~ in
whi h the e drugs were asse cd togerher with pre ise an-
alysis ofphaml: cokinetic and phanna odyn. mic charateristic
of 1'1 of them c. II differenti te the ariou. compoumb and
idl'ntify dlO~e with the b~st ost/efE acy ratio.
REfERENCES
I. Tede DW. K1eU1 jO. R"'ller 13. lhe "ru,er 0",1,,,, 011'" Medl. (;",,,1"
EpuJcnllolu~ 0 OllU, IIIcth.. l.h_lnll~ lhe lint. )Cv~'n )'C;lrlo of life 10 duldn.·f)
III ~Tt".. tCf BO(lOIl' ,1 pn,,,,p' live, ~QhUrl "Old)'. C/,,, 'lifnl n'l Il)W): 160:
H.l-·)~
2. "elglll JUl. Kl,ne MW. Hy.r' SR. Fur<.! KL II/ Grim ,ned., In: .'!I'"
RD. Cherty JD. <!<Is, T",b.",k <1 [",/'.,m t'!(""h"U OJ,,,,,,,''. rd cJn
I'llll:"lclphu Jllnde". 1'1')2; PI' 17+-11'1
), It,d.... herll ME \\C\\III~ rhe C"lc..tnnclI1 Jhrm;lllVl'" ur "lule Untl\ ml,,'(h.l.
''<4"", Iu{rtl Du} 1'''~: 13. S27- 4.
~, M.. It'nl 'J). • rhl! A, joh",,," .F.. Sh"nn I' Mc;u"nnK Ihe
COIIIJ)M".I.l.Vt' clIi ~ . of ~ult.bJ 'len.).1 .1gcllt, (br .3 ute llun, ml'~.h.l: rltt
'PolIY'nn. phen<lmemm,j P",',n', 1~12: 120: 72-7.
S, R.,..,nleld I~M, Venr... jE, 'If j. t't.1 -lnll.1 OJ J,1' ol.llImll rllh..1
droll' ," 'Cule 0"'" mew..; mel.I-a1",I)"'" or 5~IKl h,ldren rro'" t111rl)'-rhree
f,"do""<cd rn,I\.) I'fII"", I·)'J~. 124 355- ,7
,., 11,.""'l!ldd RM. WI,., l<' cxpe" rrom med••1 "",m",,, l,r ."i,i, ""'d'J,
'",I,"t/ "!/tII DII J I'J95; 14: 7.l1-8.
Klein JO. MlCroh'olollV dlie.cy 01 ••1llb.Cltn.1 drill; ror .",nt 1)l1Jt\ ",rd,.
1'.,1"", Inlrrl D" J I 'N.': 12: '173-5
II. Iloscnlcld RM. 1)0 'le WJ. S\ "' In. Scrn • I'mere Ill' Third
gcncntior1 CCph.lt01pOnl1\ In tht: ttc'~ttl1C'n' of at:llI~ pl1tumotne,"~.d tHItI\
II1cd'" '" .",,,,.1 \rudy "" 0"~"'l"\(",1 ""." "'rrlt $11'11 1')'12: t 18: ~''-52.
I • 2000 Copytight by Ihe European SooiOIY 01 ClinIcal Mloroblology and lnloCl'ouS OlsaBses. CMI. 6 (Suppl 3). 61-63
£919"(e"tddnS)9"/WJ"SOS005'O5nOllOaliJIpueA60\o,qOJOI~\eOlu'l:)10AlillOOSueodoJn3O'HAq1\161'AdoJOOOl'
'I)\.hi'V't~h.hl",·.l(~dU1/hPl'lJ'f:J
¥;~IUIl'H"rU,'UPIUPIIIrrp.llll'lUll).'1I)tIJt'III.\I'P\....Oltlt-n..·\"P....'~l'pI."
r:tJl'dllI01~ILlt'nnp:'!;t~nO'unqli;jIT],).1')111,:)(I'\"\1.lq·'ll'r.l.'dCl1mr4.:l:)L"l.
OU~~.\,','<:h(,1Jh'IlI,JIUfrlp.lUI\llItu.JlU)tqJl.\\..nll'lllIIIIJOI't'p''Ill'"
JU,lUIU';lJ)\rl'-u.ll\11\...I.l.\....lIll:\..'.""JPJ~{H,\\\drJ.ll{l1.\1'1'-,",\1,(Ilurpv('~
t(.(d'HJrt1,l\1l.l1J'~IUiUll"nJn.\tpUUlHl'l.:'If'.Jm·Ulldll)~pJ.lllqUl1!l111'~)1
JrP.\JtI.'''-'Jd{(\'\.1'f'.JJ"'1VJlUrlll".1:lp.m..'ilr.1IItI".\0I1I.1]110.1.'p1I1.1II1.'1ll'.,lJ
;11,u'1'Ul\lIllol.lllhllll'{l,.\ll''>1'''''.:lIllnUf~I)llIr~n!l.J.1\'-JllolI;lll.lXUJJ
-,1\llt~OI'l<~P-'.;,\Hllupm:J;Ipnr.,(II:'P:).\\.,I'\t'1Ir1.'q.mnu.I""Jlll"o'Ht'I"ll~~
~(l(ll'tl,L''\lllf~·.,"ItlUf
i..~'\Up.l,WS'Iul~lll"~11\\d1'.J.)tpnlll~"I4.')1"".)J~lln.)p·uo""·UUllIlIPHI
;11111f·l'.JUI..'Wo.'Jd'It~~J"lt"n"~IV)(rm..p")'UIlOpllt.'.J,)Jltl.nupHlit"lI.....Jl'lllp'
1l11t'OJ41pur.l\.Otr'JrJ.lIJlIl.l'Uon:t~IUl,)1l1_'"jl"l11I.)1l1lr,lJl,ltpUl,\I:PIXl1lIU·
-V.",,11\.1.'\IUJ);wd.:mnx,,~p\~~P,)lr,,,,)J"l'JI'fUl.I~lIlml\'ll.,))1J.'l,H1;\t1~t-;:
Ni.1·<:t'l.I'\"~lflll4tUo'I'~J",l~W1"'-1'\tn·JWltl\-)(I'Wt1'''UI1rl,\\·.fdIIJ,Jllll1IrU'I:)
It'~,.t:")II'U"ttlrw')JIlJJ/'~'IJI/',.~~""r'V"~1\:1II,lIWd'W"lp.WtlIII1·11',11ll\UUO
~llur.It,ltJ,.'lItur..U}.ltfJ1I~WJUI~tl.;xJ\11'''JOI1g.".'l'oJ!'\J.l\ru.11\\wl"'lIl~UI'lldl!r.\)
It"1;\').ll!oI1'1"()'UUJ.WfU!.,)W",)I)'f~}lHl'I~l\l."p"",'l"pLlt'IIJ"1\~
{"'If,1·r"'C:\II\1L-·:lIB1[!...l'U;'II'J,\\\'ullml'1""\H~'.\JLJ..llpmll;3ll.)
.1"..-..."G'tH'.)11'1llHJrl1-J.1lUIIP~1,'IP.,.r;lUl,,..,,.lJdt~t~lWII"qV)u·'JI'II'I'
UIflr·"IU"'UUtI;:T111""In)JtIlIX~P.l~rr'~\11'-l.'\IIP~OJJ"llll~llpndp')
\lV-I::.Ill,nurJ.JIOJput"\.'r"'~U--ilr1;)\"1IUHlO\"')\lIl.....Jqn(Iof....1.11'S·'1f1"i1l(
t"J--L'.:1~1'~'Clfll(iI(II'~1/11/1J"/II"d"lp.1tl1
'\JUo;)10)('10}l1.1l1lll.,)JJ.1lp.h,',1Ih'.I"U,)"hl""liS""'",)tlllXOlllpllpl'",\dl'l.:l41
W\.\rl'"'.\~J}O\\,.lU,),\U'.l{'lI"S,'V1'ln,lllll,1.,III'ut'IIIt\l/\\111.)O~)It:'
f;:"rlL'1'('roih~r~~,11JJrl/lll"I"rJrlp.1111,Ill'.),'lillI'Itll
M,h·J.J'p'll\.\rpIJ,')",\.l\lj'If).'"1I()11.'1I\'IIl....'III1\n)i'VI\\,,..~IlIru.111lit'
~tI""l'Yf·t~(t1.h.1"'I')\J>I~.uU4J11:J'·'I"I'HII'-IlIlI}.'UPI·til,\!.ll'l"ljl
IIIlI''IXOlllrJ'.'.....\rpU,1)".\Jnp"'J.:nto\..\rp.l.\~J~l~lIuurnlt·,\':fIIIpH'''')"''lti"II
(1)elpawSI1!IO81nJeBU!le8Jl!d!:)U!Jd
IlL\IIt'91'LhhlI'l(l1"/1I/1II"/",1
'J.''''PIl1I'\III'I~•.HII\IJU...'.lJlurIII11l..'"l1r.1Jl,1111III(lllUI."IIl:in·~i)IUIlI",')nd
,)H'IU'111'\f1'IIIIII'I\OHIJ'It'IHJJlI111Wh'l\\.111,.lUllI)1',:lItJJI'IP)".''lI.lUI1')(l
1'.''np,lJ1'111'\W'!!'"111"11.\11'[,·1II'J,.)1'(I'ItJUH'1f......llll'Jld'Vlll·tlU.l",pIII'lon
lot.,\·Lf,:L1'ol(,t..f,H<,I;1".tu·-fTlp,'llll\111It',')II'"l~'JII,lUlll',1JI
11111''1)"",'lUr''''')1'.ll~lll"t1r.11....'''..<.l'VIDI\\,'I"1U1·""I"J1"1'11\1tt'.1L..I
'jIf.("SHf,
:ft'LI11',I/f'lI,1IWIl.l'Hlt','l"('1111;{lL\JU."'.WI),Ut!lI~rp,MI.")_'t.1llllf"1I,:IJPlur't
~1I01111:1...mnIII''Hill.'1'11".1111\IHlP.,tll'V{..,n·u'~I\l(,Lml\''I'\lll'UtJI
,,~\(Il,hll1~J
6~L"ll,IJ."I'lljJ1,ll{:)'"',unl)',"11111"'11\.II'Wlh.l.......Jh~J'\"lt1tlIJlllr1'1IItHl""1;1"
,ltpIII'lo.lllII1't1'pnH·llurqd(lUI'.lU,HH~'''''I'UU'II",1II),nut·'\.1p)1V1\\lill'J)~I
(I-::t;:C:::51:C)hldI'I(JI\IIlIlw"/,.J,J'l·I}';'1I1I~IJunIII\'Ullh\UW'
III".lulI\'tUrO'1'lIlJnjdpm'"H.111''t"WHlU'tl.l(I\."l'ltV'V\\';ill'l)tl
~(l\)"",
'11~U,'d,.U(IrW1l1Ht
1
/r,'d"llI':iUUl'lldl'lll'"I"I'UI'\l1I\lUII'1"\"'111"1.1I1P
....m...l·.It,~I.\dl'J.'lp'UUllIIlW')CI.)')JII0"lp.)II.'IIOII\')-111'''11°')'-0\1'tll·"llllllj",I\~
'::~f~HI'r~(d1.,~·,.·rl!'/l'J()'J"tI'Hul1I11l1".'qltil1'lp;Ull'1111n."1III'I'
UU·I\I";U.U1t1l"dllU'10Jt!.111lU·....JI11'1.11Iur,,'lJlI1·1'L'\\"pUCI',,1.\111.1)1l"1
LS~L!..ft1lit'1'f,(llt"/ltlllt,tl.,'IU-It\','I,JI'IWttulIt'Wl'Wfj,~llj'H''''''jj'FlJ"
IlIl'l..l')""lJolluod,,oll'ltJ.l'l1'111'IIIHlllll,.,.,.1''Ip.I."UptUrtp,"lll\1J1l\111'IU,'HUJ.')d'.l
III,"IWl~nl~j.l',~lP~·)I:-hH",1'1,\1I"!1I"1I'·).'1J,lll'lH'H'l'J\1"1-IQ)"l'1'nwl'l1II
\'llIJ",,~lif\filiI
4,/lllIIUl,lll:)IIUIl"l~1/IUlltrllUlr',llllllltlllll"'ld.1"....M'./JII.")UI'1\I....lJ111111,ttt.,,",
.11'''Ill'\llllll11',""[PI'llll1"lll,llllll",h.,p'lII;'1ll1lr~JIUI1!t1l1'1\""1I11III
...)~nupp"'..PJlilt'4'I'.11f·1H"I"P'hl,l'.1lltlLH"P')"I\'.\11'1'It_tPll'\l''U\.IJI'\I01
(,l6t::bl,dIll:,!'II,tWJ,'UHJh'I()JINJ"J,IJIHI1'11',)111'111111WHllIWH,IH,1
,"'lll/l.jl/,lll,)itUl.ltlW',lll,'tpm.llllt,~p,lICl\~'ll1\P"llPttllJ,l\h.1lIV
1\1)11'1""""'0)1"Jr('''''''~'(II""''''"c,\\"'1''''1'N('"1"1"(I"-IV";;'1\1/.
